138 related articles for article (PubMed ID: 17942968)
1. Interferon-beta reduces proteinuria in experimental glomerulonephritis.
Satchell SC; Buchatska O; Khan SB; Bhangal G; Tasman CH; Saleem MA; Baker DP; Lobb RR; Smith J; Cook HT; Mathieson PW; Pusey CD
J Am Soc Nephrol; 2007 Nov; 18(11):2875-84. PubMed ID: 17942968
[TBL] [Abstract][Full Text] [Related]
2. Treatment with an antibody to VLA-1 integrin reduces glomerular and tubulointerstitial scarring in a rat model of crescentic glomerulonephritis.
Cook HT; Khan SB; Allen A; Bhangal G; Smith J; Lobb RR; Pusey CD
Am J Pathol; 2002 Oct; 161(4):1265-72. PubMed ID: 12368200
[TBL] [Abstract][Full Text] [Related]
3. Treatment with a cyclin-dependent kinase inhibitor, seliciclib, is effective in reducing glomerular macrophage numbers and the severity of established experimental glomerulonephritis.
Sheryanna AM; Smith J; Bhangal G; Barnett A; McClue S; Tam FW; Cook T; Pusey CD
Nephrology (Carlton); 2011 May; 16(4):410-6. PubMed ID: 21518118
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats.
Cook HT; Singh SJ; Wembridge DE; Smith J; Tam FW; Pusey CD
Kidney Int; 1999 Apr; 55(4):1319-26. PubMed ID: 10200996
[TBL] [Abstract][Full Text] [Related]
5. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
[TBL] [Abstract][Full Text] [Related]
6. ASK1 inhibitor treatment suppresses p38/JNK signalling with reduced kidney inflammation and fibrosis in rat crescentic glomerulonephritis.
Amos LA; Ma FY; Tesch GH; Liles JT; Breckenridge DG; Nikolic-Paterson DJ; Han Y
J Cell Mol Med; 2018 Sep; 22(9):4522-4533. PubMed ID: 29998485
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-11 attenuates nephrotoxic nephritis in Wistar Kyoto rats.
Lai PC; Cook HT; Smith J; Keith JC; Pusey CD; Tam FWK
J Am Soc Nephrol; 2001 Nov; 12(11):2310-2320. PubMed ID: 11675407
[TBL] [Abstract][Full Text] [Related]
8. Preventive effect of sulphated colominic acid on P-selectin-dependent infiltration of macrophages in experimentally induced crescentic glomerulonephritis.
Ogawa D; Shikata K; Matsuda M; Okada S; Wada J; Yamaguchi S; Suzuki Y; Miyasaka M; Tojo S; Makino H
Clin Exp Immunol; 2002 Jul; 129(1):43-53. PubMed ID: 12100021
[TBL] [Abstract][Full Text] [Related]
9. DNA vaccination against specific pathogenic TCRs reduces proteinuria in active Heymann nephritis by inducing specific autoantibodies.
Wu H; Walters G; Knight JF; Alexander SI
J Immunol; 2003 Nov; 171(9):4824-9. PubMed ID: 14568961
[TBL] [Abstract][Full Text] [Related]
10. Infusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors.
Takazawa Y; Maeshima Y; Kitayama H; Yamamoto Y; Kawachi H; Shimizu F; Matsui H; Sugiyama H; Yamasaki Y; Makino H
Kidney Int; 2005 Aug; 68(2):704-22. PubMed ID: 16014048
[TBL] [Abstract][Full Text] [Related]
11. Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumour necrosis factor-alpha.
Karkar AM; Smith J; Pusey CD
Nephrol Dial Transplant; 2001 Mar; 16(3):518-24. PubMed ID: 11239025
[TBL] [Abstract][Full Text] [Related]
12. Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats.
Isome M; Fujinaka H; Adhikary LP; Kovalenko P; El-Shemi AG; Yoshida Y; Yaoita E; Takeishi T; Takeya M; Naito M; Suzuki H; Yamamoto T
Nephrol Dial Transplant; 2004 Dec; 19(12):2997-3004. PubMed ID: 15574997
[TBL] [Abstract][Full Text] [Related]
13. Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis.
Khan SB; Cook HT; Bhangal G; Smith J; Tam FW; Pusey CD
Kidney Int; 2005 May; 67(5):1812-20. PubMed ID: 15840028
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 prevent glomerular injury in rat experimental crescentic glomerulonephritis.
Kawasaki K; Yaoita E; Yamamoto T; Tamatani T; Miyasaka M; Kihara I
J Immunol; 1993 Feb; 150(3):1074-83. PubMed ID: 8093706
[TBL] [Abstract][Full Text] [Related]
15. Sequence of events in the glomerular capillary wall at the onset of proteinuria in passive Heymann nephritis.
Fujigaki Y; Batsford S; Yamashita F; Yonemura K; Hishida A; Kawachi H; Shimizu F; Vogt A
Virchows Arch; 2001 Feb; 438(2):136-45. PubMed ID: 11253115
[TBL] [Abstract][Full Text] [Related]
16. An inhibitor of spleen tyrosine kinase suppresses experimental crescentic glomerulonephritis.
Han Y; Ma FY; Di Paolo J; Nikolic-Paterson DJ
Int J Immunopathol Pharmacol; 2018; 32():2058738418783404. PubMed ID: 29923438
[TBL] [Abstract][Full Text] [Related]
17. Glomerular expression of neuronal activity-regulated pentraxin precedes the development of anti-Thy-1-induced progressive glomerulosclerosis.
Aben JA; Ijpelaar DH; Baelde H; Worley P; Noble N; Bruijn JA; de Heer E
Kidney Int; 2006 Oct; 70(7):1279-86. PubMed ID: 16900090
[TBL] [Abstract][Full Text] [Related]
18. MK-591 acutely restores glomerular size selectivity and reduces proteinuria in human glomerulonephritis.
Guasch A; Zayas CF; Badr KF
Kidney Int; 1999 Jul; 56(1):261-7. PubMed ID: 10411701
[TBL] [Abstract][Full Text] [Related]
19. Glomerular damage in experimental proliferative glomerulonephritis under glomerular capillary hypertension.
Wang PR; Kitamura H; Shimizu A; Yamanaka N
Kidney Blood Press Res; 2015; 40(2):188-99. PubMed ID: 25871528
[TBL] [Abstract][Full Text] [Related]
20. TAK-603, an anti-inflammatory compound, reduces crescentic glomerulonephritis and preserves renal function in WKY rats.
Yamahana J; Wada T; Furuichi K; Sakai N; Yokoyama H; Kaneko S
Nephrol Dial Transplant; 2006 Oct; 21(10):2736-44. PubMed ID: 16891648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
